In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis
Figure 5
Alterations in failure strength, ultimate strength and stiffness at the femoral midshaft following 8 weeks of treatment with different combinations of alendronate (a, c, and e) and raloxifene (b, d, and f). Bars represent the mean ± SEM for each treatment group ( per group). Significant difference: *; **; *** for difference from OVX group without treatment.